BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34036718)

  • 21. FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
    Pan X; Chen Y; Biju B; Ahmed N; Kong J; Goldenberg M; Huang J; Mohan N; Klosek S; Parsa K; Guh CY; Lu R; Pickett HA; Chu HP; Zhang D
    Sci Rep; 2019 Dec; 9(1):19110. PubMed ID: 31836759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.
    Nguyen DN; Heaphy CM; de Wilde RF; Orr BA; Odia Y; Eberhart CG; Meeker AK; Rodriguez FJ
    Brain Pathol; 2013 May; 23(3):237-43. PubMed ID: 22928601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.
    Kannan K; Inagaki A; Silber J; Gorovets D; Zhang J; Kastenhuber ER; Heguy A; Petrini JH; Chan TA; Huse JT
    Oncotarget; 2012 Oct; 3(10):1194-203. PubMed ID: 23104868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATRX represses alternative lengthening of telomeres.
    Napier CE; Huschtscha LI; Harvey A; Bower K; Noble JR; Hendrickson EA; Reddel RR
    Oncotarget; 2015 Jun; 6(18):16543-58. PubMed ID: 26001292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
    Voon HPJ; Collas P; Wong LH
    Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
    Ko E; Seo HW; Jung G
    Hepatology; 2018 Apr; 67(4):1378-1391. PubMed ID: 29059467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential nuclear ATRX expression in sarcomas.
    Koelsche C; Renner M; Johann P; Leiss I; Sahm F; Schimmack S; Wardelmann E; Renker EK; Schirmacher P; Korshunov A; von Deimling A; Mechtersheimer G
    Histopathology; 2016 Apr; 68(5):738-45. PubMed ID: 26291601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative lengthening of telomeres does exist in various canine sarcomas.
    Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
    Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
    Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
    Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.
    Dogeas E; Karagkounis G; Heaphy CM; Hirose K; Pawlik TM; Wolfgang CL; Meeker A; Hruban RH; Cameron JL; Choti MA
    J Am Coll Surg; 2014 Apr; 218(4):628-35. PubMed ID: 24655849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
    Plentz RR; Schlegelberger B; Flemming P; Gebel M; Kreipe H; Manns MP; Rudolph KL; Wilkens L
    Hepatology; 2005 Sep; 42(3):522-6. PubMed ID: 16116624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
    Mangerel J; Price A; Castelo-Branco P; Brzezinski J; Buczkowicz P; Rakopoulos P; Merino D; Baskin B; Wasserman J; Mistry M; Barszczyk M; Picard D; Mack S; Remke M; Starkman H; Elizabeth C; Zhang C; Alon N; Lees J; Andrulis IL; Wunder JS; Jabado N; Johnston DL; Rutka JT; Dirks PB; Bouffet E; Taylor MD; Huang A; Malkin D; Hawkins C; Tabori U
    Acta Neuropathol; 2014 Dec; 128(6):853-62. PubMed ID: 25315281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres.
    Pan X; Drosopoulos WC; Sethi L; Madireddy A; Schildkraut CL; Zhang D
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5940-E5949. PubMed ID: 28673972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.